Commit Biologics

Commit Biologics is a biotech company in Aarhus, Denmark, founded in 2021. It has raised $85.1M across 3 rounds, most recently a $60.0M Seed in November 2026.

A Novel Immunotherapy Platform

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$85.1M
Last Round
$60.0M SeedNov 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Commit Biologics is a biotech spin-out from Aarhus University, founded in 2021, that develops a complement-engaging immunotherapy platform for cancer and autoimmune disease. Its Bispecific Complement Engaging (BiCE) technology uses single-domain antibodies that bind complement protein C1q to direct the innate immune system against tumor cells or cells implicated in autoimmune disease. The approach aims to overcome limits of conventional monoclonal antibodies, which poorly engage C1q, and to offer a broader therapeutic index than T-cell engagers or antibody-drug conjugates.

Summary

It lists 11–50 employees. It has raised $85.1M in total across 3 rounds, most recently a $60.0M Seed round in Nov 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed Financing Final CloseNov 2026
$60.0M

Sign up to see all 3 events

Funding: Seed. Amounts, valuations, and investors where available.

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Commit Biologics on Indexed.vc
<a href="https://indexed.vc/companies/commit-biologics"><img src="https://indexed.vc/api/badge/company/commit-biologics" alt="Commit Biologics on Indexed.vc" width="260" height="76" /></a>